alexa Mutation Spectrum of Survival Motor Neuron Gene in Spinal Muscular Atrophy

ISSN: 2472-1115

Journal of Down Syndrome & Chromosome Abnormalities

  • Review Article   
  • J Down Syndr Chr Abnorm 2017, Vol 3(1): 1
  • DOI: 10.4172/2472-1115.1000118

Mutation Spectrum of Survival Motor Neuron Gene in Spinal Muscular Atrophy

Isa Abdi Rad*
Department of Medical Genetics, Motahari Teaching Hospital, Urmia University of Medical Sciences, Kashani Street, Urmia, West Azerbaijan, Iran
*Corresponding Author: Isa Abdi Rad, Professor of Neurogenetics, Department of Medical Genetics, Motahari Teaching Hospital, Urmia University of Medical Sciences, Kashani Street, Urmia, West Azerbaijan, Iran, Tel: 0914 440 5829, Email: [email protected]

Received Date: Mar 14, 2017 / Accepted Date: Mar 22, 2017 / Published Date: Mar 29, 2017


Spinal muscular atrophy (SMA) is an autosomal recessive disease and characterized by symmetrical muscle weakness. All types of SMA are the result of mutations in survival motor neuron (SMN1) gene. Although, mutations in SMN1 gene are essential for pathogenesis of the disease, copy number variation in SMN2 are related to the age of onset and the severity of disease. The most common mutation on the SMN1 is homozygous deletion of exon 7 that is seen in 95%-98% of patients, followed by compound heterozygous for a deletion of exon 7 and a point mutation in the another allele of SMN1 which is seen in 2%-5% of cases. SMA patients with homozygous point mutation in SMN1 gene reported very rarely.

Keywords: Spinal muscular atrophy; SMN1 gene; Homozygous point mutation; Copy number

Clinical Aspects of SMA

Spinal muscular atrophy (SMA), with an incidence of 1/10000 world-wide [1,2] is a lower motor neuron disease and characterized by symmetrical muscle weakness and atrophy resulting from progressive degeneration of alpha motor neurons and loss of the anterior horn cells in the spinal cord and the brain stem nuclei. The inheritance pattern of SMA is autosomal recessive and classified clinically into the following types, based on the age at onset and clinical severity: SMA 0 (prenatal onset), SMA I (Werdnig-Hoffmann disease with onset before age 6 months), SMA II (Dubowitz disease with onset between age 6 and 18 months), SMA III (Kugelberg-Welander disease with onset after age 18 months), and SMA IV (onset after age 18 years). After unraveling the genetic basis of SMA, all SMN1-associated clinical types can be considered as a continuum without a clear delineation.

Survival Motor Neuron (SMN) Gene

Survival motor neuron (SMN) gene, the SMA determining gene, located on 5q12.2-q13.3 with two homologue copies, SMN1 (survival motor neuron 1; telomeric copy) and SMN2 (survival motor neuron 2; centromeric copy), which differ by only eight nucleotide (five are intronic and three are exonic, located within exons 6, 7, and 8) [3-6]. SMN1 and SMN2, both containing nine exons with 99% nucleotide identity, are arranged in tandem on each chromosome encoding a 294-amino acid RNA-binding protein. One of the coding sequence of SMN2 that differs from that of SMN1 by a single nucleotide (840 C>T) results in alternative splicing of exon 7 [4]. Due to the alternative splicing of exon 7, SMN2 genes produce a reduced amount of full length transcripts, and a variable amount of mRNA lacking exon 7, which give raise to a truncated and unstable protein [7], whereas SMN1 produces full-length transcripts.

Full-length product of SMN1 is necessary for lower motor neuron function and loss of SMN1 is essential to the pathogenesis of SMA, while SMN2 copy number modifies the severity of phenotype.

Copy Number Variation of SMN2 Gene

The number of SMN2 copies (arranged in tandem in cis configuration on each chromosome) ranges from zero to five that can be detected using quantitative PCR and MLPA methods [8,9]. The presence of three or more copies of SMN2 is associated with a milder phenotype [10-13]. All SMA patients retain at least one copy of SMN2, so, SMA is caused by low levels of SMN protein rather than complete absence of the protein. Most SMA type I patients have two copies of SMN2, three SMN2 copies are common in SMA type II, while type III and IV generally have three or four copies. On the other hand, no correlation exists between the loss of SMN1 exon 7 and the severity of disease, that is, the homozygous exon 7 deletions is observed with the same frequency in all phenotypes.

Mutation Spectrum of SMN1 Gene

Approximately 95%-98% of all types of SMA patients show homozygous deletion of SMN1 exon 7 (and exon 8 in the majority of cases) [14-16]. Approximately 6% of parents of a child with homozygous SMN1 deletion have normal results of SMN1 copy number testing because 4% of carriers have two copies of SMN1 on a single chromosome and a deletion on the other chromosome [14,17] and also de novo deletion of exon 7 of one SMN1 allele occurs in 2% of individuals with SMA [18].

Only 2-5% of SMA patients are compound heterozygous, that is, deletion of exon 7 (and exon 8) on one of their alleles and an intragenic point mutation of the SMN1 gene on the another allele [19-23]. Point mutations are dispersed all over the SMN1 gene; however, most of them are located in exons six and three that encode self-oligomerization and Tudor domains of SMN protein, respectively [24-26]. These subtle pathogenic mutations in SMN1 include base substitutions resulting in amino acid changes, splice site alterations, termination codons, and small insertions or deletions resulting in frame-shift [20,27,28]. Although, more than 60 subtle mutations of SMN1 gene have been reported worldwide [22], homozygous subtle mutations are very rarely reported in patients with SMA. Kirwin et al. reported homozygous double mutation in a SMA patient [29] and Rad et al. reported homozygous point mutation (c.549delC at exon 5) which resulted in fame-shift on SMN1 gene in a SMA type I patient [30].These reports imply that although DNA sequencing is routinely carried out on SMA patient with only one copy of SMN1 gene, it should also be carried out in patients with clinical diagnosis of SMA who show even two copies of SMN1 gene [31].


One of the following mutation conditions can occur on the SMN1 gene in the SMA patients:

1. Homozygous deletion of exon 7 (with or without deletion of exon 8) (95%-98% of cases)

2. Compound heterozygous for a deletion of exon 7 and a point mutation (2%-5% of cases)

3. Homozygous for a subtle or point mutation (very rare)


Citation: Rad IA (2017) Mutation Spectrum of Survival Motor Neuron Gene in Spinal Muscular Atrophy. J Down Syndr Chr Abnorm 3: 118. Doi: 10.4172/2472-1115.1000118

Copyright: © 2017 Rad IA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Select your language of interest to view the total content in your interested language

Post Your Comment Citation
Share This Article
Relevant Topics
Recommended Conferences
Article Usage
  • Total views: 937
  • [From(publication date): 0-2017 - Jun 18, 2018]
  • Breakdown by view type
  • HTML page views: 872
  • PDF downloads: 65

Post your comment

captcha   Reload  Can't read the image? click here to refresh
Leave Your Message 24x7